Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Short term Debt (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Short term Debt for 16 consecutive years, with $11.3 million as the latest value for Q3 2025.

  • Quarterly Short term Debt fell 12.25% to $11.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Sep 2025, down 12.25% year-over-year, with the annual reading at $12.1 million for FY2024, 162.22% up from the prior year.
  • Short term Debt for Q3 2025 was $11.3 million at Xtant Medical Holdings, down from $12.0 million in the prior quarter.
  • The five-year high for Short term Debt was $16.5 million in Q1 2021, with the low at $720000.0 in Q3 2022.
  • Average Short term Debt over 5 years is $7.2 million, with a median of $4.6 million recorded in 2023.
  • The sharpest move saw Short term Debt surged 1648900.0% in 2021, then plummeted 79.36% in 2022.
  • Over 5 years, Short term Debt stood at $3.6 million in 2021, then fell by 6.66% to $3.4 million in 2022, then skyrocketed by 36.79% to $4.6 million in 2023, then surged by 162.22% to $12.1 million in 2024, then decreased by 6.7% to $11.3 million in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $11.3 million, $12.0 million, and $11.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.